RxDoctor Payments Data

Michael Kressler, DPM

Foot & Ankle Surgery · Reno, NVNPI 1184628174

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Organogenesis Inc. at 42.9% of the total. That places this record below the midpoint for foot & ankle surgery clinicians in NV, where the typical reported total is $3,921.

$1,723in general payments, 2019–2025

Across 60 payments — averaging $28.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$739
  • Smith+Nephew$367
  • Osiris Therapeutics Inc.$139
  • Bone Support Inc.$135
  • Medtronic$85
  • Urgo Medical North America, LLC$50
  • plus $208 from 8 others

What the payments were for

  • Food & beverage$1,723100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,723 in reported general payments places this provider in the 35th percentile of 84 foot & ankle surgery providers in Nevada.

See all foot & ankle surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$138,343
Medicare patients
361
Services billed
1,815

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin101$1,542
Doxycycline Hyclate27$199
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha12$154
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$149
Meloxicam54$108
Methylprednisolone16$104
Cephalexin17$91
Silver Sulfadiazine11$85
Amoxicillin13$34

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →